als toward evidence-based management of dysarthria

104
Amyotrophic lateral sclerosis: Toward evidence-based management of dysarthria Kathryn M. Yorkston, PhD, BC- NCD Laura Ball, PhD David R. Beukelman, PhD Pamela Mathy, PhD

Upload: ariefsuryowidodo

Post on 10-Dec-2015

214 views

Category:

Documents


0 download

DESCRIPTION

towered

TRANSCRIPT

Page 1: ALS Toward Evidence-based Management of Dysarthria

Amyotrophic lateral sclerosis: Toward evidence-based management of dysarthria

Kathryn M. Yorkston, PhD, BC-NCD

Laura Ball, PhD

David R. Beukelman, PhD

Pamela Mathy, PhD

Page 2: ALS Toward Evidence-based Management of Dysarthria

2

Website

http://www.ticeinfo.com

http://aac.unl.edu

Page 3: ALS Toward Evidence-based Management of Dysarthria

3

Amyotrophic Lateral Sclerosis (ALS) Degenerative motor neuron disease Muscle atrophy and spasticity In the limbs and bulbar muscles Dysarthria and dysphagia are common Decisions for SLP re: types & timing of:

– speech intervention– AAC intervention

Page 4: ALS Toward Evidence-based Management of Dysarthria

4

Overview

• An introduction to evidence-based decision making• Yorkston - University of Washington

• Question 1: How can early bulbar symptoms be identified?

• Ball - University of Nebraska, Omaha• Question 2: What techniques are appropriate for maintenance of natural speech in progressive dysarthria?

• Beukelman, University of Nebraska, Lincoln• Question 3: Are AAC techniques effective in maintaining communication in ALS?

• Mathy, Arizona State University

Page 5: ALS Toward Evidence-based Management of Dysarthria

5

Introduction of Terms

Evidence-based practice

Practice guidelines

Staging of intervention

Page 6: ALS Toward Evidence-based Management of Dysarthria

6

Toward Evidence-Based Practice

Medical students do the wrong things in a clinical setting not because of a deficiency in knowledge, but because they don’t make good decisions. They know a lot, but they don’t think systematically.

(Arthur Elstein, Ph.D, University of Illinois, presenting a lecture at University of Washington, April 27, 1999).

Page 7: ALS Toward Evidence-based Management of Dysarthria

7

Evidence-Based Practice

. . is a commitment to a constant reexamination of practices through research and outcomes analyses.

- Enhancing our knowledge-base

- Enhancing our decision making

[Sackett et al., (1997)]

Page 8: ALS Toward Evidence-based Management of Dysarthria

8

Evidence-Based Practice

. . an approach to decision making in which the clinician uses the best evidence available, in consultation with the patient, to decide upon the option which suits that patient best.”

[Muir Gray, 1997]

Page 9: ALS Toward Evidence-based Management of Dysarthria

9

Evidence-based practice is of interest to: Practitioners Policymakers Payers Purchasers Patients Public

Page 10: ALS Toward Evidence-based Management of Dysarthria

10

Definition: Practice Guidelines

Clinical practice guidelines are explicit descriptions of how patients should be evaluated and treated. The explicit purpose of guidelines is to improve the quality of care and to assure it by reducing variation in care provided.

- review of evidence- consensus of experts

Page 11: ALS Toward Evidence-based Management of Dysarthria

11

Practice GuidelinesExamples from ALS “breaking the news” to patients and

families, nutrition and PEG placements, respiratory insufficiency and mechanical

ventilation, management of emotional lability, and palliative care.

American Academy of NeurologyMiller et al, 1999

Page 12: ALS Toward Evidence-based Management of Dysarthria

12

ANCDS - Practice Guidelines

Velopharyngeal Management

Behavioral Tx of Respiration/Phonation

Surgical/Pharm. Tx of Phonation

Speech Supplementation Tx of Speech Rate &

Naturalness

Technical Report due Nov. 2000

Ready for expert review Jan. 2001

Ready for expert review Jan. 2001

Ready for expert review Dec. 2000

To be drafted, 2001

Page 13: ALS Toward Evidence-based Management of Dysarthria

13

Definition: Staging

. . . the sequencing of management so that current problems are addressed and future problems anticipated.

Page 14: ALS Toward Evidence-based Management of Dysarthria

14

ALS: Stage 1

No Detectable Speech Disorder

. . Diagnosis has been made, but often speakers do not yet exhibit speechsymptoms in those with spinal presentation.

Page 15: ALS Toward Evidence-based Management of Dysarthria

15

ALS: Stage 2

Obvious Speech Disorder withIntelligible Speech

. . both the speaker and listener noticechanges in speech - speakers may perceiveextra effort needed for speech.

Page 16: ALS Toward Evidence-based Management of Dysarthria

16

ALS: Stage 3

Reduction in Speech Intelligibility

. . . changes in speaking rate, articulation, and resonance are all evident.

Page 17: ALS Toward Evidence-based Management of Dysarthria

17

ALS: Stage 4

Natural Speech - Supplemented

. . . natural speech is no longer afunctional means of communication in all situations.

Page 18: ALS Toward Evidence-based Management of Dysarthria

18

ALS: Stage 5

No Functional Speech

. . . speakers with advance bulbar ALShave lost functional speech due to profoundweakness.

Page 19: ALS Toward Evidence-based Management of Dysarthria

19

Staging

• Question 1: How can early bulbar symptoms be identified?

• Stages 1 and 2 - Early intervention

•Question 2: What techniques are appropriate for maintenance of natural speech in progressive dysarthria?

• Stages 3 and 4 - Moderate to severe dysarthria

•Question 3: Are AAC techniques effective in maintaining communication in ALS?

• Stage 4 and 5: Severe to profound dysarthria

Page 20: ALS Toward Evidence-based Management of Dysarthria

How can early bulbar symptoms be identified?

Laura J. Ball, Ph.D.

Page 21: ALS Toward Evidence-based Management of Dysarthria

21

Rationale

With the advent of new drug interventions for ALS, early diagnosis & identification of bulbar symptoms has become critical.

(Quality Standard Subcommittee of the American Academy of

Neurology, 1997)

Page 22: ALS Toward Evidence-based Management of Dysarthria

22

Diagnostic techniques that may be implemented to facilitate early identification of bulbar ALS symptoms have become essential for pharmaceutical & communication interventions.

Page 23: ALS Toward Evidence-based Management of Dysarthria

23

Review of literature

In the 1990’s, treatments were tested to slow ALS progression. Decision-making regarding these interventions requires – information to place these treatments in the

context of other treatments and – to understand the significance of the efficacy

these treatments may show.

Many drug trials target addressing the earliest possible signs of ALS.

Page 24: ALS Toward Evidence-based Management of Dysarthria

24

Bulbar Characteristics

Speech & swallowing symptoms usually parallel -- 71% of 200 consecutive visits(Yorkston, Miller & Strand, 1995)

First symptoms involve:– swallowing difficulties – dysarthric speech– possible nasal resonance changes– laryngeal changes

Page 25: ALS Toward Evidence-based Management of Dysarthria

25

Focus on Bulbar Characteristics of Dysarthria

“Neurological or neuromuscular damage causing paralysis, paresis, or incoordination in the bulbar or spinal sensorimotor systems can affect the range, velocity, force, or timing of speech movements as well as the respiratory processes that support speech production.” (Warren, Rochet, Hinton,

1997, p. 81)

Page 26: ALS Toward Evidence-based Management of Dysarthria

26

ALS Dysarthria Database

N = 218 visits of persons with ALS documented

Protocol measurement includes numerous factors including intelligibility, speaking rate, aerodynamic measures of oral pressure & nasal air flow, VP descriptor from aerodynamic measures, communication effectiveness ratings (self & listener), & ALS Severity Rating Scale

Page 27: ALS Toward Evidence-based Management of Dysarthria

27

ALS Database Questions

Who is going to need AAC? How soon do we know they will need AAC? What will predict loss of intelligible speech

with sufficient time to implement functional interventions?– Assess– Acquire Device– Training

Page 28: ALS Toward Evidence-based Management of Dysarthria

28

Question 1

Who is going to need AAC?How do we identify bulbar

characteristics of dysarthria?

How do we assess speech characteristics?

Page 29: ALS Toward Evidence-based Management of Dysarthria

29

Speech Assessment Strategies

Intelligibility Speaking Rate Aerodynamic Measurements Pattern of Velopharyngeal Closure ALS Speech Severity Scale Communication Effectiveness

Page 30: ALS Toward Evidence-based Management of Dysarthria

30

Intelligibility

Sentence Intelligibility Test (Yorkston, Beukelman & Tice, 1991)

– Measures intelligibility in sentences– Scored by unfamiliar (to speaker &

content) listener– Obtain % intelligibility

Page 31: ALS Toward Evidence-based Management of Dysarthria

31

Speaking Rate

Sentence Intelligibility Test Speaking rate in sentences Obtain rate in words per minute

Page 32: ALS Toward Evidence-based Management of Dysarthria

32

Rate & Intelligibility

“Changes in speech rate and oral diadokokinetic rates may be precursors of changes in speech intelligibility.”

(Yorkston,Strand, Miller, Hillel & Smith, 1993)

Page 33: ALS Toward Evidence-based Management of Dysarthria

33

Rate & Intelligibility

Information obtained from the UNMC database is consistent with previous research, in that when rate decreases to half of normal (or approximately 100 wpm) for an individual with ALS, a precipitous decline in intelligibility may be expected.

R2 = .828, p = .000

Page 34: ALS Toward Evidence-based Management of Dysarthria

34

Page 35: ALS Toward Evidence-based Management of Dysarthria

35

Gary’s Progression

A 40 year old male with bulbar onset of symptoms….

09/1999: 97% intelligible, rate 90wpm

11/1999: 75% intelligible, rate 68wpm

02/2000: 33% intelligible, rate 52wpm

05/2000: 6.8% intelligible, rate 36wpm

Page 36: ALS Toward Evidence-based Management of Dysarthria

36

Aerodynamic Measurement Rationale

Accurate description of speech deficits

Develop new treatment approaches Demonstrate quantifiable changes

in physiologic responses(Warren, Rochet, Hinton,

1997)

Page 37: ALS Toward Evidence-based Management of Dysarthria

37

Aerodynamic Measurement of Speech Productions

Air Flow Meter – (pneumotachograph with nasal mask)– Normally no flow unless /m, n, /

Air Pressure Transducer – (flexible tube placed laterally on tongue)– Normal between 3-8cm H2O)

Page 38: ALS Toward Evidence-based Management of Dysarthria

38

Pattern of VP ClosureObtained from Aeros printouts. 1. VP closure on pressure consonants 2. Initial VP insufficiency, eventually closes 3. VP insufficiency on some consonants,

approximates but never closes 4. Initial VP closure, insufficient by end of

utterance 5. Excessive VP insufficiency on all

pressure consonants

Page 39: ALS Toward Evidence-based Management of Dysarthria

39

VP Closure & Intelligibility

Consistent with Intelligibility and Speaking Rate measures, VP closure and Intelligibility measures remain fairly steady until the person with ALS completely and consistently loses velopharyngeal closure.

R2 = -.393, p=.005

Page 40: ALS Toward Evidence-based Management of Dysarthria

40

VP Closure & Speaking Rate

Examination of data assessing VP closure and Speaking Rate indicate a pattern similar to that identified with Speaking Rate and Intelligibility.

When Speaking Rate approximates 100wpm, Intelligibility takes a rapid & precipitous decline.

Page 41: ALS Toward Evidence-based Management of Dysarthria

41

VP Closure & Rate

Likewise, when Speaking Rate approximates 120wpm, the Pattern of VP closure changes to demonstrate progressively more consistent VP incompetence. Another decline is observed at the 100wpm mark.

These data indicate that VP Closure Pattern/Rate changes precede Intelligibility/ Rate changes in persons with ALS.

Page 42: ALS Toward Evidence-based Management of Dysarthria

42

VP Closure & ALS Speech Rating

Pearson Product-Moment Correlation

(R2 = -.417 p = .002) With increase in VP rating,

observe lower ALS Speech Ratings

Page 43: ALS Toward Evidence-based Management of Dysarthria

43

Question 2

How soon do we know about the loss of natural speech?

Page 44: ALS Toward Evidence-based Management of Dysarthria

44

Communication Effectiveness Modified Index (Lomas, 1989)

Measure societal limitation

perceived when communicating Likert-type scale

– 0 = not at all able– 6 = very effective

10 contextual situations

Page 45: ALS Toward Evidence-based Management of Dysarthria

45

I am effective at conversing with:1. familiar persons in a quiet environment.2. strangers in a quiet environment.3. a familiar person over the phone.4. young children.5. a stranger over the phone.6. while traveling in a car.7. someone at a distance.8. someone in a noisy environment.9. before a group.10. someone in a long conversation (>1 hour).

Page 46: ALS Toward Evidence-based Management of Dysarthria

46

Intelligibility & Communication Effectiveness

Communication effectiveness scores followed a stair-step decline following a decline in intelligibility.

Page 47: ALS Toward Evidence-based Management of Dysarthria

47

Communication effectiveness declines occurred at...

1st at 95% > intelligibility (m = 5.5)!! 2nd at 90-95% intelligibility (m = 4.7) 3rd at 80-90% intelligibility (m = 3.7) 4th at 70-80% intelligibility (m = 2.3) Final at < 70% intelligibility (m = 1.5)

Page 48: ALS Toward Evidence-based Management of Dysarthria

48

Intelligibility & Communication Effectiveness

Page 49: ALS Toward Evidence-based Management of Dysarthria

49

Intelligibility & Communication Effectiveness

With some slight (nonsignificant) differences, speakers with ALS and their frequent communication partners (spouses, children, caregivers) demonstrate similar descriptions of communication effectiveness.

Page 50: ALS Toward Evidence-based Management of Dysarthria

50

Recommendations

It is recommended that evidence-based speech assessment strategies be implemented into a protocol to facilitate early identification of bulbar ALS symptoms.

Early identification may promote earlier diagnosis of ALS & provide a more reasonable timeline to physicians wishing to implement drug trials & patients wishing to take advantage of them.

Page 51: ALS Toward Evidence-based Management of Dysarthria

51

Maintaining the Use of Natural Speech (David Beukelman)

Behavioral Interventions

Environmental Interventions

Prosthodontic Interventions

Supplemented Speech Interventions

Page 52: ALS Toward Evidence-based Management of Dysarthria

52

Behavioral Interventions Speaking rate modification Speakers usually reduce rate with intervention--

especially with cognitive changes. Maintain coordinated respiratory patterns Coordinated thoracic and abdominal breath

(speech & grammatical structure) Reduce fatigue Conserve energy for communication Eliminate oral or non-speech exercises

Page 53: ALS Toward Evidence-based Management of Dysarthria

53

Prosthodontic Interventions

Palatal lift

Palatal augmentation (drop-down)

Voice amplification

Page 54: ALS Toward Evidence-based Management of Dysarthria

54

Palatal Lift Evidence

Gonzalez & Aronson (1970). Aten, et al. (1984).

Esposito et al. (2000) retrospective study 21 of 25 speakers with ALS decreased hypernasality 2 of 25 refused to wear the lift 4 of 25 received no benefit Progression of tongue and lip weakness almost always

cause for lack of benefit.

Page 55: ALS Toward Evidence-based Management of Dysarthria

55

Palatal Augmentation

Esposito et al (2000).

Page 56: ALS Toward Evidence-based Management of Dysarthria

56

Environmental Interventions

Optimize hearing of frequent listeners

Optimize adverse speaking situations– Reduce background noise– Mute TV– Amplify speaker in meetings, groups, & noise– “Private conference room” –

Page 57: ALS Toward Evidence-based Management of Dysarthria

57

Supplemented Speech Interventions Alphabet Supplementation

Topic Supplementation

Mixed Topic & Alphabet Supplementation

Gestural Supplementation

Page 58: ALS Toward Evidence-based Management of Dysarthria

58

Information from Speech Signal

(Speech Intelligibility)

Information from Non-speech Sources

Understanding

Poor

Poor

Rich

Rich

Mutuality Model (Lindbolm, 1990)

Page 59: ALS Toward Evidence-based Management of Dysarthria

59

Intelligibility

Acoustic Signal

Speech Impairment&

Compensatory Strategies

ListenerProcessing

Speech Intelligibility

Language KnowledgeWorld Knowledge

Disability Knowledge

Page 60: ALS Toward Evidence-based Management of Dysarthria

60

Speech Signal Information Speech Impairment

& Compensatory Strategies

AcousticSignal

ListenerProcessing

Speech Comprehensibility

Signal-IndependentInformation Semantic Context Syntactic Context Alphabet Gestures

Comprehensibility

Language KnowledgeWorld Knowledge

Disability Knowledge

Page 61: ALS Toward Evidence-based Management of Dysarthria

61

Alphabet + Semantic Topic BoardSmall Talk

FamilyFamily

Personal

Transportation

Trips

Weather

Shopping

ChurchFood

Sports

Start over

Health

A B C D E F G

H I J K L M N O

P Q R S T U V

W X Y Z

No

Yes

Please repeat words

Point to first letter

Will spell words

Schedule

Wait

Don’t know

Maybe

Forget it

Please stop

Not finished

Not done

Page 62: ALS Toward Evidence-based Management of Dysarthria

62

Alphabet Supplementation

Beukelman & Yorkston (1977)– 42% & 47% improvement in intelligibility (TBI & BS Stroke)

Schumacher & Rosenbek (1986)– 57% improvement in intelligibility (PD)

Hustad (1999) (Pilot for Dissertation)– 42.5% Improvement in Intelligibility (CP)

Crow & Enderby (1989)– 15% Mean improvement in intelligibility (speech signal only) (mixed group of

speakers)

Hustad & Beukelman (Submitted)– 19% Mean improvement in intelligibility (Alphabet information with habitual

speech) (CP)

Page 63: ALS Toward Evidence-based Management of Dysarthria

63

Topic Supplementation

(Dongilli, 1994)

Page 64: ALS Toward Evidence-based Management of Dysarthria

64

Topic Supplementation (Con’t)

Carter et al. (1996).– 9% Mean improvement in intelligibility

Hustad & Beukelman (1998)– 10% Improvement in intelligibility

Hustad & Beukelman (Submitted)– 10% mean improvement in intelligibility (Topic

information with habitual speech (CP).

Page 65: ALS Toward Evidence-based Management of Dysarthria

65

Semantic Supplemented Speech

(Hammen, Yorkston, &

Dowden, 1991)

Speaker Group Sentence Intell(%) Sentence Intell(%)

No Context Semantic Context

Profound 2 20

Severe 27 67

Moderate 64 96

Page 66: ALS Toward Evidence-based Management of Dysarthria

66

Mixed (Topic + Alphabet) Supplementation Hunter, Pring, and Martin (1991) 15% relative to topic cues only.

Hustad & Beukelman (Submitted) 34% Mean improvement for mixed

compared to no cues (Mixed cues with habitual speech) (CP)

Page 67: ALS Toward Evidence-based Management of Dysarthria

67

Gestural Cues

Garcia & Cannito (1996). – 25% Improvement in low predictive context– 22.5 Improvement in high predictive context

Page 68: ALS Toward Evidence-based Management of Dysarthria

68

Techniques for Improving Comprehensibility (Speaker-1) Provide listener with context Don’t shift topics abruptly Use turn-taking signals Get your listener’s attention Use complete sentences Use predictable types of sentences Use predictable wording Rephrase you message

Yorkston, Beukelman, Strand, & Bell, 1999

Page 69: ALS Toward Evidence-based Management of Dysarthria

69

Techniques for Improving Comprehensibility (Speaker--2) Accompany speech with simple gestures Take advantage of situational cues Make environment as friendly as possible Avoid communication over long distances Use alphabet board supplementation Have a handy backup system

Yorkston, Beukelman, Strand, & Bell, 1999

Page 70: ALS Toward Evidence-based Management of Dysarthria

70

Techniques for Improving Comprehensibility: (Listener-1) Know topic of conversation Watch for turn-taking signals Give your undivided attention Choose time and place to talk Watch the speaker Piecing together the cues Make the environment work for you Avoid communicating over long distances

Yorkston, Beukelman, Strand, & Bell, 1999

Page 71: ALS Toward Evidence-based Management of Dysarthria

71

Techniques for Improving Comprehensibility (Listener-2) Make sure your hearing is as good as possible Decide on and incorporate strategies for

resolving communication breakdowns Establish some rules of the game Facilitate communication with others

Yorkston, Beukelman, Strand, & Bell, 1999

Page 72: ALS Toward Evidence-based Management of Dysarthria

72

AAC & ALS

Pam Mathy

Page 73: ALS Toward Evidence-based Management of Dysarthria

AAC Methods Used By Individuals Who Have ALS (Pam Mathy)

Unassisted methods--these methods do not involve any form of chart or electronic device

Low tech methods--these methods use some form of chart (e.g., alphabet board) and some means to access it (e.g., finger, light pointer, partner scan). Also included here is handwriting (e.g., paper, pencil, dry-erase boards, magic slate)

Page 74: ALS Toward Evidence-based Management of Dysarthria

74

Laser Pointer With Alphabet Board

Page 75: ALS Toward Evidence-based Management of Dysarthria

75

Partner Assisted Manual Scan Board

.

I YOU A AND ON GET

TO IT IN DO IF FOR

THE IS OF BUT BE I'M

MY

ME

THIS SO WILL GO NOT OR

THAT CAN WITH WAS HOW

LIKE AREDON'TWHATHAVE

1. E A S T O

2.

3.

4.

5.

N R U I H F J

L Y

C W K M B Q Z

XVPDG

6.

7.

8.

9.

10.

SPACE STARTOVER

Page 76: ALS Toward Evidence-based Management of Dysarthria

76

Partner Assisted Manual Scanning

Page 77: ALS Toward Evidence-based Management of Dysarthria

77

Handwriting Using “White Board”

Page 78: ALS Toward Evidence-based Management of Dysarthria

78

AAC Methods Used By Individuals Who Have ALS

High tech methods--these methods involve use of an electronic device– Uni-Access Devices: Synthesized Speech Devices

Accessed Primarily Using Manual Direct Selection (e.g., LightWriter, Link, IMPACT)

– Multi-Access Devices: Synthesized Speech Devices Designed To Support Multiple Access Methods (e.g., Freedom 2000, DynaVox)

Page 79: ALS Toward Evidence-based Management of Dysarthria

79

Uni-Access Devices: LightWriter Series--Zygo

Dual display, direct select & scanning, DECtalk, custom-keyboardarrangement, very portable, letter-coding,phrase storage.

Page 80: ALS Toward Evidence-based Management of Dysarthria

80

Uni-Access Devices: Link—Assistive Technology Inc.

Direct-selectionaccess only,Letter-coding,Phrase storage,DECtalk,Standard size keyboard,Relatively low-cost.

Page 81: ALS Toward Evidence-based Management of Dysarthria

81

Uni-Access Devices: IMPACT—ENKIDU Research

Handheld Portable IMPACT combines a large keyboard (80% of full size) with a touchscreen to provide additional methods of message production. The expanded touchscreen means that you can have more (or larger) onscreen buttons, allowing for more varied augmentative interfaces. With its nylon carrying case, the Handheld can be used effectively while standing or sitting. Inputs:Touchscreen, keyboard, scanning.

Page 82: ALS Toward Evidence-based Management of Dysarthria

82

Multi-Access Devices: E Z Keys for Windows—Words +

Page 83: ALS Toward Evidence-based Management of Dysarthria

83

Multi-Access Devices: DynaVox Sunrise Medical

Page 84: ALS Toward Evidence-based Management of Dysarthria

84

Switches and Mounts

Slimarmstrong (Ablenet)

Jellybean switch (Ablenet)

Page 85: ALS Toward Evidence-based Management of Dysarthria

85

Decision Parameters in AAC Intervention Disease Progression Employment Status Age Motivation to Communicate Support (family, friend, employer)

Page 86: ALS Toward Evidence-based Management of Dysarthria

86

Disease Progression

Using ALS severity scale (ALSSS) (Hillel, Miller,

Yorkston, McDonald, Norris & Konikow, 1989 Yorkston, et. al. (1993) followed

101 individuals Fifty eight men Fifty two women

Across 303 clinic visits Six profiles were identified based on Speech,

Upper Extremity and Lower Extremity Functioning

Page 87: ALS Toward Evidence-based Management of Dysarthria

87

Functioning Cutoffs on ALSSS Used to Identify Groupings

Adequate speech = 5 or greater (Stages 1 – 3). Poor speech = 4 or less (Stages 4 and 5) Adequate UE = 5 or greater (partial – complete

use of UE) Poor UE = 4 or less (needs assistance in self-

care, can’t use pencil/pen) Adequate LE = 7 or greater (noticeable gait

changes – normal ambulation) Poor LE = 6 or less (impaired mobility--requires

cane, walker, wheelchair)

Page 88: ALS Toward Evidence-based Management of Dysarthria

88

Disease Progression Groupings Identified by Yorkston, et. al.

Group 1 (46.5%)--adequate speech, adequate UE Group 2 (20%)--adequate speech, poor UE Group 3 (16%)--poor speech, adequate UE and LE Group 4 (8%)--poor speech, adequate UE, poor LE Group 5 (2.5%)--poor speech, poor UE, adequate

LE Group 6 (7%)--poor speech, UE and LE

Page 89: ALS Toward Evidence-based Management of Dysarthria

89

AAC Interventions Used by Disease

Progression Group Group 1 (46.5%)--adequate speech,

adequate UE– None– Portable amplifiers– Alphabet Supplementation

Page 90: ALS Toward Evidence-based Management of Dysarthria

90

AAC Interventions Used by Disease Progression Group

Group 2 (20%)--adequate speech, poor UE – None– Portable amplifiers– Alphabet Supplementation– Assess for writing augmentation (computer

access) if desired--writing now--speech later

Page 91: ALS Toward Evidence-based Management of Dysarthria

91

AAC Interventions Used by Disease Progression Group

Group 3 (16%)--poor speech, adequate UE and LE– Low tech alphabet boards/supplementation– Handwriting

“Magic slate” “White boards”

– High tech devices depending on needs Community, work, car

– Portable, keyboard-based Phone

– Talking word processors, email for home computer– TTD, FAX

Page 92: ALS Toward Evidence-based Management of Dysarthria

92

AAC Methods Used by Patients With Bulbar Presentation (Groups 3 & 4)

Page 93: ALS Toward Evidence-based Management of Dysarthria

93

Category of AAC Method(s) Used “Most of the Time” by Communicative Activity

Conversation

Quick Needs

Detailed Needs

Phone

In depth Info.

Written Comm

Stories

0 2 4 6 8 10 12Number of Patients (Total N=12)

No Tech

Handwriting

Other Low Tech

High Tech

Doesn't Participate

Bulbar Presentation Patients

Page 94: ALS Toward Evidence-based Management of Dysarthria

94

AAC Interventions Used by Disease Progression Group

Group 4 (8%)--poor speech, adequate UE, poor LE– Most issues similar to group 3

Portable AAC devices can be mounted on wheelchair

– Attention getting devices

Page 95: ALS Toward Evidence-based Management of Dysarthria

95

AAC Interventions Used by Disease Progression Group

Group 5 (2.5%)--poor speech, poor UE, adequate LE– No tech partner dependent auditory scanning– Low tech partner dependent visual scanning– Low tech optical pointing– Portability needs – High tech dedicated and/or multipurpose systems

Light weight, portable Adaptations to home computer

– Attention getting devices

Page 96: ALS Toward Evidence-based Management of Dysarthria

96

AAC Interventions Used by Disease Progression Group

Group 6 (7%)--poor speech, UE and LE– No tech partner dependent auditory scanning– Low tech partner dependent visual scanning– Low tech optical pointing– High tech dedicated and/or multipurpose

systems Check needs for portability--wheelchair mounting Adaptations to home computer

– Attention getting devices

Page 97: ALS Toward Evidence-based Management of Dysarthria

97

AAC Methods Used by Patients With Spinal Presentation (Groups 5 and 6)

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

v

x

x

x

x

x

x

S

S

S

S

S

D (optical pointer)

S

S

S

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

J,P

D,D

I,G

C,A

J,M

O,O

P,M

P,W

L,L

L,J-1

L,J-2

E,V

Dep. Aud. Scanning Facial Expr.

Yes/No Questions

Yes/No Hier.Coded Eye-Blink

Alphabet Board (S or D)

Call Buzzer

Multipurpose Device

Page 98: ALS Toward Evidence-based Management of Dysarthria

98

Category of AAC Method(s) Used “Most of the Time” by Communicative Activity

Conversation

Quick Needs

Detailed Needs

Phone

In depth Info.

Written Comm

Stories

0 2 4 6 8 10 12Number of Patients (Total N=12)

No Tech

Low Tech

High Tech

Doesn't Participate

Spinal Presentation Patients

Page 99: ALS Toward Evidence-based Management of Dysarthria

99

Overall AAC Method Use Breakdown by Communicative Activity (N=6)

Co

nve

rsat

ion

Bas

ic N

eed

s

Det

aile

d N

eed

s

Det

aile

d I

nfo

rmat

ion

Sto

ries

0

10

20

30

40

50

60

70

80

90

100

Mea

n P

erc

enta

ge

No Tech

Low Tech

High Tech

Page 100: ALS Toward Evidence-based Management of Dysarthria

100

Use of AAC Methods by Partner Familiarity (N=6)

Co

nve

rsat

ion

Wit

h

Ver

y F

amil

iar

Par

tner

Bas

ic N

eed

s W

ith

V

ery

Fam

ilia

r P

artn

er

Co

nve

rsat

ion

Wit

h S

tran

ger

Bas

ic N

eed

s W

ith

Str

ang

er

0

10

20

30

40

50

60

70

80

90

100

Mea

n P

erc

enta

ge

No Tech

Low Tech

High Tech

Page 101: ALS Toward Evidence-based Management of Dysarthria

101

Satisfaction With AAC Methods by Communicative Activity (N=6)

Co

nve

rsat

ion

Qu

ick

Bas

ic N

eed

s

Det

aile

d N

eed

s

Det

aile

d I

nfo

rmat

ion

Sto

ries

Wri

tten

Co

mm

un

ica

tio

n0

1

2

3

4

5

6

Su

bje

cts

N=

6

7 (Very Satisfied )

6

5

4 (Neutral)

3

2

1 (Very Dissatisfied)

Page 102: ALS Toward Evidence-based Management of Dysarthria

102

Related References

Yorkston, Miller, Strand (1995). Management of speech and swallowing in degenerative diseases. Tuscon, AZ: Communication Skill Builders.

Warren, Rochet, Hinton. (1997). Aerodynamics. In (M. McNeil, Ed.) Clinical management of sensorimotor speech disorders. NY: Thieme.

Lomas, Pickard, Bester, Elbard, Finlayson, & Zoghaib (1989). The communication effectiveness index: Development and psychometric evaluation of a functional communication measure for adult aphasia. JSHD, 54 (1), 113-124.

Page 103: ALS Toward Evidence-based Management of Dysarthria

103

More references

Mathy, P., Yorkston, K. M., & Gutmann, M. (2000). Augmentative communication for individuals with amyotrophic lateral sclerosis. In D. R. Beukelman, K. M. Yorkston, & J. Reichle (Eds.), Augmentative communication in adults . Baltimore, MD: Paul H. Brookes.

Yorkston, K. M., Beukelman, D. R., Strand, E. A., & Bell, K. R. (1999). Management of motor speech disorders in children and adults. Austin, TX: Pro-Ed.

Page 104: ALS Toward Evidence-based Management of Dysarthria

104

More references Miller, R. G., et al. (1999). Practice parameter: The

care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 52, 1311-1323.

Sackett, D. L., Richardson, W. S., Rosenberg, W., & Haynes, R. B. (1997). Evidence-based medicine. New York: Churchill Livingstone.

Yorkston, Beukelman, & Tice. (1991) Sentence Intelligibility Test. Lincoln, NE: Tice Technologies.